Toxicity in isolated lung perfusion with melphalan for resectable lung metastases Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology Year: 2006
Combination chemotherapy with gemcitabine using isolated lung perfusion for the treatment of lung metastases Source: Eur Respir J 2004; 24: Suppl. 48, 42s Year: 2004
Temozolomide in the treatment of brain metastases in lung cancer patients Source: Eur Respir J 2003; 22: Suppl. 45, 65s Year: 2003
Pre-operative chemotherapy in patients with resectable non-small cell lung cancer (NSCLC): the MRC LU22/NVALT/EORTC 08012 multi-centre randomised trial Source: Eur Respir J 2007; 30: Suppl. 51, 240s Year: 2007
A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2003; 22: Suppl. 45, 162s Year: 2003
A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012
Factors predicting complete surgical resection after induction chemotherapy in patients with initially unresectable non-small cell lung cancer (NSCLC) treated in a randomised trial Source: Eur Respir J 2003; 22: Suppl. 45, 162s Year: 2003
Resectability after two different chemotherapy regimens: results of the first step of a phase II randomised trial in initially resectable stage I – IIIa nonsmall cell lung cancer conducted by the European lung cancer working party Source: Eur Respir J 2003; 22: Suppl. 45, 162s Year: 2003
Brain metastases in lung cancer patients Source: International Congress 2019 – ME4 Brain metastases in lung cancer patients. Year: 2019
A retrospective study of lung parenchymal damage after neoadjuvant chemo and radiotherapy for non small cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 464s Year: 2002
Comparative evaluation of resectability, postoperative morbidity and mediastinal downstaging after cisplatin-based chemoinduction versus radiochemoinduction for stage III non-small cell lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 214s Year: 2003
Early complications after lung resections at patients treated for lung cancer with and without neoadjuvant hemiotheraphy Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011
Treatment modalities in lung cancer patients with brain metastasis Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012
Asymptomatic brain metastases in lung cancer patients Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008
Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer: a prospective multicentre study Source: Eur Respir J, 50 (6) 1701493; 10.1183/13993003.01493-2017 Year: 2017
The estimations of two regimenes of radiation of brain metastases in patients with primary lung cancer Source: Annual Congress 2007 - Therapy of thoracic malignancies Year: 2007
Carboplatin and paclitaxel chemotherapy for lung cancer patients with interstitial lung disease Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010
Possibility of the specific efficacy of gefitinib for miliary lung metastasis in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 303s Year: 2004
Survival and postoperative complication after neoadjuvant therapy in resectable stage IIIA-N2 non-small cell lung cancer: a balancing exercise Source: Eur Respir J 2003; 22: Suppl. 45, 31s Year: 2003